Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions
- PMID: 3510323
- DOI: 10.1067/mva.1986.avs0030104
Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions
Abstract
Autologous saphenous vein (ASV) and polytetrafluoroethylene (PTFE) grafts were compared in 845 infrainguinal bypass operations, 485 to the popliteal artery and 360 to infrapopliteal arteries. Life-table primary patency rates for randomized PTFE grafts to the popliteal artery paralleled those for randomized ASV grafts to the same level for 2 years and then became significantly different (4-year patency rate of 68% +/- 8% [SE] for ASV vs. 47% +/- 9% for PTFE, p less than 0.025). Four-year patency differences for randomized above-knee grafts were not statistically significant (61% +/- 12% for ASV vs. 38% +/- 13% for PTFE, p greater than 0.25) but were for randomized below-knee grafts (76% +/- 9% for ASV vs. 54% +/- 11% for PTFE, p less than 0.05). Four-year limb salvage rates after bypasses to the popliteal artery to control critical ischemia did not differ for the two types of randomized grafts (75% +/- 10% for ASV vs. 70% +/- 10% for PTFE, p greater than 0.25). Although primary patency rates for randomized and obligatory PTFE grafts to the popliteal artery were significantly different (p less than 0.025), 4-year limb salvage rates were not (70% +/- 10% vs. 68% +/- 20%, p greater than 0.25). Primary patency rates at 4 years for infrapopliteal bypasses with randomized ASV were significantly better than those with randomized PTFE (49% +/- 10% vs. 12% +/- 7%, p less than 0.001). Limb salvage rates at 3 1/2 years for infrapopliteal bypasses with both randomized grafts (57% +/- 10% for ASV and 61% +/- 10% for PTFE) were better than those for obligatory infrapopliteal PTFE grafts (38% +/- 11%, p less than 0.01). These results fail to support the routine preferential use of PTFE grafts for either femoropopliteal or more distal bypasses. However, this graft may be used preferentially in selected poor-risk patients for femoropopliteal bypasses, particularly those that do not cross the knee. Although every effort should be made to use ASV for infrapopliteal bypasses, a PTFE distal bypass is a better option than a primary major amputation.
Similar articles
-
Patency of infrainguinal polytetrafluoroethylene bypass grafts with distal interposition vein cuffs.Cardiovasc Surg. 1998 Feb;6(1):19-26. doi: 10.1016/s0967-2109(97)00093-8. Cardiovasc Surg. 1998. PMID: 9546843
-
Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction.Surgery. 1982 Dec;92(6):921-30. Surgery. 1982. PMID: 6755789 Clinical Trial.
-
Femoropopliteal bypass with either adequate ipsilateral reversed saphenous vein or obligatory polytetrafluoroethylene.Ann Vasc Surg. 1994 Sep;8(5):475-84. doi: 10.1007/BF02133068. Ann Vasc Surg. 1994. PMID: 7811585 Clinical Trial.
-
A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.J Vasc Surg. 2014 Aug;60(2):506-15. doi: 10.1016/j.jvs.2014.05.049. Epub 2014 Jun 25. J Vasc Surg. 2014. PMID: 24973288 Review.
-
Adjuncts to improve patency of infrainguinal prosthetic bypass grafts.Vasc Endovascular Surg. 2003 Nov-Dec;37(6):381-6. doi: 10.1177/153857440303700601. Vasc Endovascular Surg. 2003. PMID: 14671692 Review.
Cited by
-
Current advances in the translation of vascular tissue engineering to the treatment of pediatric congenital heart disease.Yale J Biol Med. 2012 Jun;85(2):229-38. Epub 2012 Jun 25. Yale J Biol Med. 2012. PMID: 22737051 Free PMC article. Review.
-
Saphenous vein ablation a word of caution.J Vasc Surg Venous Lymphat Disord. 2024 Jul;12(4):101728. doi: 10.1016/j.jvsv.2023.101728. Epub 2024 Jan 19. J Vasc Surg Venous Lymphat Disord. 2024. PMID: 38244858 Free PMC article. No abstract available.
-
Late failure of reversed vein bypass grafts.Ann Surg. 1989 Dec;210(6):782-6. doi: 10.1097/00000658-198912000-00015. Ann Surg. 1989. PMID: 2589891 Free PMC article.
-
Endovascular-First Treatment Is Associated With Improved Amputation-Free Survival in Patients With Critical Limb Ischemia.Circ Cardiovasc Qual Outcomes. 2019 Aug;12(8):e005273. doi: 10.1161/CIRCOUTCOMES.118.005273. Epub 2019 Jul 30. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31357888 Free PMC article.
-
Tissue engineering of the vascular system: from capillaries to larger blood vessels.Med Biol Eng Comput. 2000 Mar;38(2):232-40. Med Biol Eng Comput. 2000. PMID: 10829419 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical